This recent commentary featured in The Lancet Diabetes Endocrinal 2017 focuses on the need for coordinated efforts and a large international database of patients with diabetes and nephropathy.
It refers to ISN and its Advancing Clinical Trials group and Clinical Trial Networks who could be instrumental in achieving this objective.
Read more HERE.
The ISN Academy is committed to delivering high-quality educational resources to... read more
The ISN recognizes the importance of global research initiatives in advancing... read more
The “ISN Global Kidney Trials Insights: A Guide for Everyone”... read more
The ISN is pleased to announce the signing of a new... read more
Kidney International® Patients With Crush Syndrome and Kidney Disease: Lessons Learned From... read more
Staff from Dalal Jamm Hospital and Cliniques Universitaires St. Luc during... read more
In 2024, the ISN welcomed new Affiliated and Collective-member societies, extending... read more
The #ISNWCN Social Media Team will be on hand at WCN’25... read more
The 2024 ISN leadership elections are underway from November 4 to... read more
Calling all early-career researchers! Have you published original research in Kidney International®... read more
